Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: Mechanistic insights

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 668, Issue 1-2, 2009, Pages 54-72

  Thompson, Larry H ^a   Hinz, John M ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Chromosomal instability; Crosslink repair; DNA crosslinking; DNA replication forks; Homologous recombination repair; Mutagenesis; Translesion synthesis

Indexed keywords

ATR PROTEIN; BRCA1 PROTEIN; DIHYDROFOLATE REDUCTASE; DNA; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FANCONI ANEMIA A ASSOCIATED PROTEIN 100; FANCONI ANEMIA A ASSOCIATED PROTEIN 24; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP B PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP I PROTEIN; FANCONI ANEMIA GROUP J PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA GROUP N PROTEIN; FANCONI ANEMIA PROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NIBRIN; RAD51 PROTEIN; UNCLASSIFIED DRUG;

CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CHROMOSOMAL INSTABILITY; COMPLEX FORMATION; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; FANCONI ANEMIA; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SISTER CHROMATID EXCHANGE; VDJ EXON;

ANIMALS; CHO CELLS; CHROMOSOMAL INSTABILITY; CRICETINAE; CRICETULUS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; MODELS, GENETIC; MUTATION; OXIDATIVE STRESS; SISTER CHROMATID EXCHANGE;

EID: 67349107395     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.02.003     Document Type: Review

References (283)

1. Fanconi G. Hypothesis of chromosomal translocation as a genetic interpretation of Fanconi's familial constitutional panmyelopathy. Helv. Paediatr. Acta 19 (1964) 29-33
2. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 97 (2003) 425-440
3. Tischkowitz M.D., and Hodgson S.V. Fanconi anaemia. J. Med. Genet. 40 (2003) 1-10
4. Mathew C.G. Fanconi anaemia genes and susceptibility to cancer. Oncogene 25 (2006) 5875-5884
5. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8 (2007) 735-748
6. Patel K.J., and Joenje H. Fanconi anemia and DNA replication repair. DNA Repair (Amst.) 6 (2007) 885-890
7. Gurtan A.M., and D'Andrea A.D. Dedicated to the core: understanding the Fanconi anemia complex. DNA Repair 5 (2006) 1119-1125
8. Taniguchi T., and D'Andrea A.D. The molecular pathogenesis of Fanconi anemia: recent progress. Blood 107 (2006) 4223-4233
9. Buchwald M., and Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage?. Mutat. Res. 408 (1998) 75-90
10. Levitus M., Joenje H., and de Winter J.P. The Fanconi anemia pathway of genomic maintenance. Cell. Oncol. 28 (2006) 3-29
11. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Staltenpool J., Stone S., Dorkal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W. A DNA translocase homologous to an ancient DNA repair protein is defective in Fanconi anemia. Nat. Genet. 37 (2005) 958-963
12. Gari K., Decaillet C., Stasiak A.Z., Stasiak A., and Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 29 (2008) 141-148
13. Xue Y., Li Y., Guo R., Ling C., and Wang W. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 17 (2008) 1641-1652
14. Kim J.M., Kee Y., Gurtan A., and D'Andrea A.D. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 111 (2008) 5215-5222
15. Meetei A.R., De Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., Van De Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
16. Meetei A.R., Yan Z., and Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 3 (2004) 179-181
17. Seki S., Ohzeki M., Uchida A., Hirano S., Matsushita N., Kitao H., Oda T., Yamashita T., Kashihara N., Tsubahara A., Takata M., and Ishiai M. A requirement of FancL and FancD2 monoubiquitination in DNA repair. Genes Cells 12 (2007) 299-310
18. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
19. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald III E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., and Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 (2007) 289-301
20. Sims A.E., Spiteri E., Sims III R.J., Arita A.G., Lach F.P., Landers T., Wurm M., Freund M., Neveling K., Hanenberg H., Auerbach A.D., and Huang T.T. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14 (2007) 564-567
21. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
22. Xia B., Sheng Q., Nakanishi K., Ohashi A., Wu J., Christ N., Liu X., Jasin M., Couch F.J., and Livingston D.M. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22 (2006) 719-729
23. Cantor S.B., Bell D.W., Ganesan S., Kass E.M., Drapkin R., Grossman S., Wahrer D.C., Sgroi D.C., Lane W.S., Haber D.A., and Livingston D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160
24. Levran O., Attwooll C., Henry R.T., Milton K.L., Neveling K., Rio P., Batish S.D., Kalb R., Velleuer E., Barral S., Ott J., Petrini J., Schindler D., Hanenberg H., and Auerbach A.D. The BRCA1 interacting helicase BACH1/BRIP1 is deficient in Fanconi anemia. Nat. Genet. 37 (2005) 931-933
25. Litman R., Peng M., Jin Z., Zhang F., Zhang J., Powell S., Andreassen P.R., and Cantor S.B. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8 (2005) 255-265
26. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghabzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., Arwert F., Mathew C.G., Zdzienicka M.Z., Hiom K., De Winter J.P., and Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J. Nat. Genet. 37 (2005) 934-935
27. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A.R., Laghmani el H., Joenje H., McDonald N., de Winter J.P., Wang W., and West S.C. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25 (2007) 331-343
28. Ling C., Ishiai M., Ali A.M., Medhurst A.L., Neveling K., Kalb R., Yan Z., Xue Y., Oostra A.B., Auerbach A.D., Hoatlin M.E., Schindler D., Joenje H., de Winter J.P., Takata M., Meetei A.R., and Wang W. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26 (2007) 2104-2114
29. Rahman N., Seal S., Thompson D., Kelly P., Renwick A., Elliott A., Reid S., Spanova K., Barfoot R., Chagtai T., Jayatilake H., McGuffog L., Hanks S., Evans D.G., Eccles D., Easton D.F., and Stratton M.R. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39 (2007) 165-167
30. Tischkowitz M., Xia B., Sabbaghian N., Reis-Filho J.S., Hamel N., Li G., van Beers E.H., Li L., Khalil T., Quenneville L.A., Omeroglu A., Poll A., Lepage P., Wong N., Nederlof P.M., Ashworth A., Tonin P.N., Narod S.A., Livingston D.M., and Foulkes W.D. Analysis of PALB2/FANCN-associated breast cancer families. Proc. Natl. Acad. Sci. USA 104 (2007) 6788-6793
31. Eelen G., Vanden Bempt I., Verlinden L., Drijkoningen M., Smeets A., Neven P., Christiaens M.R., Marchal K., Bouillon R., and Verstuyf A. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. Oncogene 27 (2008) 4233-4241
32. Sasaki M.S., and Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 33 (1973) 1829-1836
33. Ishida R., and Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 42 (1982) 4000-4006
34. Sasaki M.S. Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links?. Nature 257 (1975) 501-503
35. Fujiwara Y., and Tatsumi M. Cross-link repair in human cells and its possible defect in Fanconi's anemia cells. J. Mol. Biol. 113 (1977) 635-649
36. Fujiwara Y. Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells. Biochim. Biophys. Acta 699 (1982) 217-225
37. Averbeck D., Papadopoulo D., and Moustacchi E. Repair of 4,5′,8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines. Cancer Res. 48 (1988) 2015-2020
38. Matsumoto A., Vos J.M., and Hanawalt P.C. Repair analysis of mitomycin C-induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients. Mutat. Res. 217 (1989) 185-192
39. Kaye J., Smith C.A., and Hanawalt P.C. DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin. Cancer Res. 40 (1980) 696-702
40. Poll E.H., Arwert F., Kortbeek H.T., and Eriksson A.W. Fanconi anaemia cells are not uniformly deficient in unhooking of DNA interstrand crosslinks, induced by mitomycin C or 8-methoxypsoralen plus UVA. Hum. Genet. 68 (1984) 228-234
41. Sobeck A., Stone S., Costanzo V., de Graaf B., Reuter T., de Winter J., Wallisch M., Akkari Y., Olson S., Wang W., Joenje H., Christian J.L., Lupardus P.J., Cimprich K.A., Gautier J., and Hoatlin M.E. Fanconi Anemia proteins are required to prevent accumulation of replication associated DNA double-strand breaks. Mol. Cell. Biol. 26 (2006) 425-427
42. Hinz J.M., Nham P.B., Urbin S.S., Jones I.M., and Thompson L.H. Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res. 35 (2007) 3733-3740
43. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2 (2001) 446-457
44. Kitao H., Yamamoto K., Matsushita N., Ohzeki M., Ishiai M., and Takata M. Functional interplay between BRCA2/FancD1 and FancC in DNA repair. J. Biol. Chem. 281 (2006) 21312-21320
45. Lieber M.R. The mechanism of human nonhomologous DNA end joining. J. Biol. Chem. 283 (2008) 1-5
46. Weterings E., and Chen D.J. The endless tale of non-homologous end-joining. Cell Res. 18 (2008) 114-124
47. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356 (1992) 763-767
48. Ishiai M., Kitao H., Smogorzewska A., Tomida J., Kinomura A., Uchida E., Saberi A., Kinoshita E., Kinoshita-Kikuta E., Koike T., Tashiro S., Elledge S.J., and Takata M. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 15 (2008) 1138-1146
49. McCulloch S.D., and Kunkel T.A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18 (2008) 148-161
50. Loeb L.A., and Monnat Jr. R.J. DNA polymerases and human disease. Nat. Rev. Genet. 9 (2008) 594-604
51. Mirchandani K.D., McCaffrey R.M., and D'Andrea A.D. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair 7 (2008) 902-911
52. Mosedale G., Niedzwiedz W., Alpi A., Perrina F., Pereira-Leal J.B., Johnson M., Langevin F., Pace P., and Patel K.J. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12 (2005) 763-771
53. Pagano G., and Youssoufian H. Fanconi anaemia proteins: major roles in cell protection against oxidative damage. Bioessays 25 (2003) 589-595
54. Bagby G.C., and Alter B.P. Fanconi anemia. Semin. Hematol. 43 (2006) 147-156
55. Fagerlie S.R., and Bagby G.C. Immune defects in Fanconi anemia. Crit. Rev. Immunol. 26 (2006) 81-96
56. Kruyt F.A., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., and Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92 (1998) 3050-3056
57. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., and Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7 (2001) 814-820
58. Futaki M., Igarashi T., Watanabe S., Kajigaya S., Tatsuguchi A., Wang J., and Liu J.M. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 23 (2002) 67-72
59. Park S.J., Ciccone S.L., Beck B.D., Hwang B., Freie B., Clapp D.W., and Lee S.H. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J. Biol. Chem. 279 (2004) 30053-30059
60. Joenje H., Arwert F., Eriksson A.W., de Koning H., and Oostra A.B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 290 (1981) 142-143
61. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., and Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20 (1998) 281-283
62. de Winter J.P., Rooimans M.A., van Der Weel L., van Berkel C.G., Alon N., Bosnoyan-Collins L., de Groot J., Zhi Y., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G., Scheper R.J., Hoatlin M.E., Buchwald M., and Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24 (2000) 15-16
63. de Winter J.P., Leveille F., van Berkel C.G., Rooimans M.A., van Der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K., Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., and Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67 (2000) 1306-1308
64. Deschavanne P.J., Debieu D., Fertil B., and Malaise E.P. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int. J. Radiat. Biol. 50 (1986) 279-293 [published erratum appears in Int. J. Radiat. Biol. 50(6, Dec.) (1986) 1129]
65. Carreau M., Alon N., Bosnoyan-Collins L., Joenje H., and Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat. Res. 435 (1999) 103-109
66. Tebbs R.S., Hinz J.M., Yamada N.A., Wilson J.B., Salazar E.P., Thomas C.B., Jones I.M., Jones N.J., and Thompson L.H. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 4 (2005) 11-22
67. Yamamoto K., Hirano S., Ishiai M., Morishima K., Kitao H., Namikoshi K., Kimura M., Matsushita N., Arakawa H., Buerstedde J.M., Komatsu K., Thompson L.H., and Takata M. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell. Biol. 25 (2005) 34-43
68. Hirano S., Yamamoto K., Ishiai M., Yamazoe M., Seki M., Matsushita N., Ohzeki M., Yamashita Y.M., Arakawa H., Buerstedde J.M., Enomoto T., Takeda S., Thompson L.H., and Takata M. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24 (2005) 418-427
69. Nomura Y., Adachi N., Koyama H., and Human Mus81. FANCB independently contribute to repair of DNA damage during replication. Genes Cells 12 (2007) 1111-1122
70. Deschavanne P.J., and Fertil B. A review of human cell radiosensitivity in vitro. Int. J. Radiat. Oncol. Biol. Phys. 34 (1996) 251-266
71. Yamamoto K., Ishiai M., Matsushita N., Arakawa H., Lamerdin J.E., Buerstedde J.M., Tanimoto M., Harada M., Thompson L.H., and Takata M. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23 (2003) 5421-5430
72. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
73. Nojima K., Hochegger H., Saberi A., Fukushima T., Kikuchi K., Yoshimura M., Orelli B.J., Bishop D.K., Hirano S., Ohzeki M., Ishiai M., Yamamoto K., Takata M., Arakawa H., Buerstedde J.M., Yamazoe M., Kawamoto T., Araki K., Takahashi J.A., Hashimoto N., Takeda S., and Sonoda E. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65 (2005) 11704-11711
74. Lamerdin J.E., Yamada N.A., George J.W., Souza B., Christian A.T., Jones N.J., and Thompson L.H. Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3. Mutagenesis 19 (2004) 237-244
75. Tebbs R.S., Zhao Y., Tucker J.D., Scheerer J.B., Siciliano M.J., Hwang M., Liu N., Legerski R.J., and Thompson L.H. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl. Acad. Sci. USA 92 (1995) 6354-6358
76. Hinz J.M., Tebbs R.S., Wilson P.F., Nham P.B., Salazar E.P., Nagasawa H., Urbin S.S., Bedford J.S., and Thompson L.H. Repression of mutagenesis by Rad51D-mediated homologous recombination. Nucleic Acids Res. 34 (2006) 1358-1368
77. Jones N.J., Cox R., and Thacker J. Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster cells. Mutat. Res. 183 (1987) 279-286
78. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., and Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA crosslinks and other damages. Mol. Cell 1 (1998) 783-793
79. Yang Y., Kuang Y., De Oca R.M., Hays T., Moreau L., Lu N., Seed B., and D'Andrea A.D. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98 (2001) 3435-3440
80. Peng M., Litman R., Jin Z., Fong G., and Cantor S.B. BACH1 is a DNA repair protein supporting BRCA1 damage response. Oncogene 25 (2006) 2245-2253
81. Kalb R., Duerr M., Wagner M., Herterich S., Gross M., Digweed M., Joenje H., Hoehn H., and Schindler D. Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat. Res. 161 (2004) 318-325
82. Godthelp B.C., van Buul P.P., Jaspers N.G., Elghalbzouri-Maghrani E., van Duijn-Goedhart A., Arwert F., Joenje H., and Zdzienicka M.Z. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Mutat. Res. 601 (2006) 191-201
83. Hatanaka A., Yamazoe M., Sale J.E., Takata M., Yamamoto K., Kitao H., Sonoda E., Kikuchi K., Yonetani Y., and Takeda S. Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination. Mol. Cell. Biol. 25 (2005) 1124-1134
84. German J. The chromosome-breakage syndromes: rare disorders that provide models for studying somatic mutation. In: Spatz L., Bloom A.D., and Paul N.W. (Eds). Detection of Cancer Predisposition: Laboratory Approaches (1990), March of Dimes Birth Defects Foundation, White Plains, NY 85-111
85. Setlow R.B. Repair deficient human disorders and cancer. Nature 271 (1978) 713-717
86. Auerbach A.D., and Wolman S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261 (1976) 494-496
87. Higurashi M., and Conen P.E. In vitro chromosomal radiosensitivity in "chromosomal breakage syndromes". Cancer 32 (1973) 380-383
88. Chaganti R.S.K., Schonberg S., and German J. A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc. Natl. Acad. Sci. USA 71 (1974) 4508-4512
89. Auerbach A.D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol. 21 (1993) 731-733
90. Newell A.E., Akkari Y.M., Torimaru Y., Rosenthal A., Reifsteck C.A., Cox B., Grompe M., and Olson S.B. Interstrand crosslink-induced radials form between non-homologous chromosomes, but are absent in sex chromosomes. DNA Repair 3 (2004) 535-542
91. Hinz J.M., Nham P.B., Salazar E.P., and Thompson L.H. The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair 5 (2006) 875-884
92. Adelfalk C., Lorenz M., Serra V., von Zglinicki T., Hirsch-Kauffmann M., and Schweiger M. Accelerated telomere shortening in Fanconi anemia fibroblasts-a longitudinal study. FEBS Lett. 506 (2001) 22-26
93. Hanson H., Mathew C.G., Docherty Z., and Mackie Ogilvie C. Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach. Cytogenet. Cell Genet. 93 (2001) 203-206
94. Callen E., Samper E., Ramirez M.J., Creus A., Marcos R., Ortega J.J., Olive T., Badell I., Blasco M.A., and Surralles J. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum. Mol. Genet. 11 (2002) 439-444
95. London T.B., Barber L.J., Mosedale G., Kelly G.P., Balasubramanian S., Hickson I.D., Boulton S.J., and Hiom K. FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts. J. Biol. Chem. 283 (2008) 36132-36139
96. Wu Y., Shin-ya K., and Brosh Jr. R.M. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol. Cell. Biol. 28 (2008) 4116-4128
97. Simonsson T. G-quadruplex DNA structures-variations on a theme. Biol. Chem. 382 (2001) 621-628
98. Kan Z.Y., Lin Y., Wang F., Zhuang X.Y., Zhao Y., Pang D.W., Hao Y.H., and Tan Z. G-quadruplex formation in human telomeric (TTAGGG)4 sequence with complementary strand in close vicinity under molecularly crowded condition. Nucleic Acids Res. 35 (2007) 3646-3653
99. Maizels N. Genomic stability: FANCJ-dependent G4 DNA repair. Curr. Biol. 18 (2008) R613-614
100. Akkari Y.M., Bateman R.L., Reifsteck C.A., Olson S.B., and Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell. Biol. 20 (2000) 8283-8289
101. Wang X., Peterson C.A., Zheng H., Nairn R.S., Legerski R.J., and Li L. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol. Cell. Biol. 21 (2001) 713-720
102. Zhang N., Zhang X., Peterson C., Li L., and Legerski R. Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts. Nucleic Acids Res. 28 (2000) 4800-4804
103. Rothfuss A., and Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 24 (2004) 123-134
104. Zheng H., Wang X., Warren A.J., Legerski R.J., Nairn R.S., Hamilton J.W., and Li L. Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol. Cell. Biol. 23 (2003) 754-761
105. Raschle M., Knipsheer P., Enoiu M., Angelov T., Sun J., Griffith J.D., Ellenberger T.E., Scharer O.D., and Walter J.C. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 134 (2008) 969-980
106. Li L., Peterson C.A., Lu X., Wei P., and Legerski R.J. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol. Cell. Biol. 19 (1999) 5619-5630
107. Zhang N., Lu X., Zhang X., Peterson C.A., and Legerski R.J. hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. Cell. Biol. 22 (2002) 2388-2397
108. Zhang N., Liu X., Li L., and Legerski R. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair 6 (2007) 1670-1678
109. Kumaresan K.R., and Lambert M.W. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis 21 (2000) 741-751
110. Kumaresan K.R., Sridharan D.M., McMahon L.W., and Lambert M.W. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells. Biochemistry 46 (2007) 14359-14368
111. Kumaresan K.R., Hwang M., Thelen M.P., and Lambert M.W. Contribution of XPF functional domains to the 5′ and 3′ incisions produced at the site of a psoralen interstrand cross-link. Biochemistry 41 (2002) 890-896
112. Sridharan D.M., McMahon L.W., and Lambert M.W. alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. Cell Biol. Int. 30 (2006) 866-878
113. McMahon L.W., Sangerman J., Goodman S.R., Kumaresan K., and Lambert M.W. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 40 (2001) 7025-7034
114. Sridharan D., Brown M., Lambert W.C., McMahon L.W., and Lambert M.W. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell Sci. 116 (2003) 823-835
115. Lefferts J.A., Wang C., Sridharan D., Baralt M., and Lambert M.W. The SH3 domain of alphaII spectrin is a target for the fanconi anemia protein, FANCG. Biochemistry 48 (2009) 254-263
116. Lundberg R., Mavinakere M., and Campbell C. Deficient DNA end joining activity in extracts from Fanconi anemia fibroblasts. J. Biol. Chem. 276 (2001) 9543-9549
117. Escarceller M., Rousset E., Moustacchi E., and Papadopoulo D. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia. Somat. Cell Mol. Genet. 23 (1997) 401-411
118. Escarceller M., Buchwald M., Singleton B.K., Jeggo P.A., Jackson S.P., Moustacchi E., and Papadopoulo D. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J. Mol. Biol. 279 (1998) 375-385
119. Donahue S.L., and Campbell C. A DNA double strand break repair defect in Fanconi anemia fibroblasts. J. Biol. Chem. 277 (2002) 46243-46247
120. Houghtaling S., Newell A., Akkari Y., Taniguchi T., Olson S., and Grompe M. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Hum. Mol. Genet. 14 (2005) 3027-3033
121. Donahue S.L., Lundberg R., Saplis R., and Campbell C. Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts. J. Biol. Chem. 278 (2003) 29487-29495
122. Thyagarajan B., and Campbell C. Elevated homologous recombination activity in fanconi anemia fibroblasts. J. Biol. Chem. 272 (1997) 23328-23333
123. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. USA 102 (2005) 1110-1115
124. Yang Y.G., Herceg Z., Nakanishi K., Demuth I., Piccoli C., Michelon J., Hildebrand G., Jasin M., Digweed M., and Wang Z.Q. The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis 26 (2005) 1731-1740
125. Bridge W.L., Vandenberg C.J., Franklin R.J., and Hiom K. The BACH1/BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37 (2005) 934-935
126. Ohashi A., Zdzienicka M.Z., Chen J., and Couch F.J. FANCD2 functions independently of BRCA2 and RAD51 associated homologous recombination in response to DNA damage. J. Biol. Chem. 280 (2005) 14877-14883
127. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., and Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 (2002) 1121-1126
128. Pichierri P., Averbeck D., and Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11 (2002) 2531-2546
129. Donahue S.L., and Campbell C. A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts. Nucleic Acids Res. 32 (2004) 3248-3257
130. Casado J.A., Nunez M.I., Segovia J.C., Ruiz de Almodovar J.M., and Bueren J.A. Non-homologous end-joining defect in Fanconi anemia hematopoietic cells exposed to ionizing radiation. Radiat. Res. 164 (2005) 635-641
131. Smith J., Andrau J.C., Kallenbach S., Laquerbe A., Doyen N., and Papadopoulo D. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J. Mol. Biol. 281 (1998) 815-825
132. Donahue S.L., Tabah A.A., Schmitz K., Aaron A., and Campbell C. Defective signal joint recombination in fanconi anemia fibroblasts reveals a role for Rad50 in V(D)J recombination. J. Mol. Biol. 370 (2007) 449-458
133. In: Wolff S. (Ed). Sister Chromatid Exchange (1982), John Wiley & Sons, New York
134. Wilson III D.M., and Thompson L.H. Molecular mechanisms of sister-chromatid exchange. Mutat. Res. 616 (2007) 11-23
135. Wu L., and Hickson I.D. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 426 (2003) 870-874
136. Evans H.J. Sister chromatid exchanges and disease states in man. In: Wolff S. (Ed). Sister Chromatid Exchange (1982), John Wiley & Sons, New York 183-228
137. Gebhart E., Kysela D., Matthee H., and Nikol M. Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals. Hum. Genet. 69 (1985) 309-315
138. Miura K., Morimoto K., and Koizumi A. Proliferative kinetics and mitomycin C-induced chromosome damage in Fanconi's anemia lymphocytes. Hum. Genet. 63 (1983) 19-23
139. Porfirio B., Dallapiccola B., Mokini V., Alimena G., and Gandini E. Failure of diepoxybutane to enhance sister chromatid exchange levels in Fanconi's anemia patients and heterozygotes. Hum. Genet. 63 (1983) 117-120
140. Wilson J.B., Johnson M.A., Stuckert A.P., Trueman K.L., May S., Bryant P.E., Meyn R.E., D'Andrea A.D., and Jones N.J. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis 22 (2001) 1939-1946
141. Kraakman-van der Zwet M., Overkamp W.J., van Lange R.E., Essers J., van Duijn-Goedhart A., Wiggers I., Swaminathan S., van Buul P.P., Errami A., Tan R.T., Jaspers N.G., Sharan S.K., Kanaar R., and Zdzienicka M.Z. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22 (2002) 669-679
142. Latt S.A., Stetten G., Juergens L.A., Buchanan G.R., and Gerald P.S. Induction by alkylating agents of sister chromatid exchanges and chromatid breaks in Fanconi's anemia. Proc. Natl. Acad. Sci. USA 72 (1975) 4066-4070
143. Billardon B., and Moustacchi E. Comparison of the sensitivity of Fanconi's anemia and normal fibroblasts to the induction of sister-chromatid exchanges by photoaddition of mono- and bi-functional psoralens. Mutat. Res. 174 (1986) 241-246
144. Porfirio B., Dallapiccola B., and Gandini E. The effect of aphidicolin on Fanconi's anemia lymphocyte chromosomes. Mutat. Res. 144 (1985) 257-263
145. Takata M., Kitao H., and Ishiai M. Fanconi anemia: genetic analysis of a human disease using chicken system. Cytogenet. Genome Res. 117 (2007) 346-351
146. Takata M., Yamamoto K., Matsushita N., Kitao H., Hirano S., and Ishiai M. The Fanconi anemia pathway promotes homologous recombination repair in DT40 cell line. Subcell. Biochem. 40 (2006) 295-311
147. Smiraldo P.G., Gruver A.M., Osborn J.C., and Pittman D.L. Extensive chromosomal instability in Rad51d-deficient mouse cells. Cancer Res. 65 (2005) 2089-2096
148. Takata M., Sasaki M.S., Tachiiri S., Fukushima T., Sonoda E., Schild D., Thompson L.H., and Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21 (2001) 2858-2866
149. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: Replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
150. Finkelberg R., Buchwald M., and Siminovitch L. Decreased mutagenesis in cells from patients with Fanconi's anemia. Am. J. Hum. Genet. 29 (1977) 42A
151. Papadopoulo D., Porfirio B., and Moustacchi E. Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens. Cancer Res. 50 (1990) 3289-3294
152. Papadopoulo D., Guillouf C., Mohrenweiser H., and Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. USA 87 (1990) 8383-8387
153. Papadopoulo D., Laquerbe A., Guillouf C., and Moustacchi E. Molecular spectrum of mutations induced at the HPRT locus by a cross-linking agent in human cell lines with different repair capacities. Mutat. Res. 294 (1993) 167-177
154. Guillouf C., Laquerbe A., Moustacchi E., and Papadopoulo D. Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells. Mutagenesis 8 (1993) 355-361
155. Laquerbe A., Moustacchi E., Fuscoe J.C., and Papadopoulo D. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination. Proc. Natl. Acad. Sci. USA 92 (1995) 831-835
156. Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., and Kinoshita T. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259 (1993) 1318-1320
157. Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L., Notaro R., and Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res. 65 (2005) 8111-8117
158. Bredberg A., Sandor Z., and Brant M. Mutational response of Fanconi anaemia cells to shuttle vector site-specific psoralen cross-links. Carcinogen. 16 (1995) 555-562
159. Sala-Trepat M., Boyse J., Richard P., Papadopoulo D., and Moustacchi E. Frequencies of HPRT-lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors. Mutat. Res. 289 (1993) 115-126
160. Evdokimova V.N., McLoughlin R.K., Wenger S.L., and Grant S.G. Use of the glycophorin A somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype. Am. J. Med. Genet. A 135 (2005) 59-65
161. Laquerbe A., Sala-Trepat M., Vives C., Escarceller M., and Papadopoulo D. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients. Mutat. Res. 431 (1999) 341-350
162. Cox R.P., Krauss M.R., Balis M.E., and Dancis J. Evidence for transfer of enzyme product as the basis of metabolic cooperation between tissue culture fibroblasts of Lesch-Nyhan disease and normal cells. Proc. Natl. Acad. Sci. USA 67 (1970) 1573-1579
163. Luria S.E., and Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28 (1943) 491-511
164. Xu Z., Yu Y., Schwartz J.L., Meltz M.L., and Hsie A.W. Molecular nature of spontaneous mutations at the hypoxanthine-guanine phosphoribosyltransferase (hprt) locus in Chinese hamster ovary cells. Environ. Mol. Mutagen. 26 (1995) 127-138
165. Lee H., Larner J.M., and Hamlin J.L. Cloning and characterization of Chinese hamster p53 cDNA. Gene 184 (1997) 177-183
166. Hu T., Miller C.M., Ridder G.M., and Aardema M.J. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat. Res. 426 (1999) 51-62
167. Tlsty T.D., Margolin B.H., and Lum K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. USA 86 (1989) 9441-9445
168. Albertson D.G. Gene amplification in cancer. Trends Genet 22 (2006) 447-455
169. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., and Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 (1992) 923-935
170. Giulotto E., Knights C., and Stark G.R. Hamster cells with increased rates of DNA amplification, a new phenotype. Cell 48 (1987) 837-845
171. Lockwood W.W., Chari R., Coe B.P., Girard L., Macaulay C., Lam S., Gazdar A.F., Minna J.D., and Lam W.L. DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27 (2008) 4615-4624
172. Mondello C., Rebuzzini P., Dolzan M., Edmonson S., Taccioli G.E., and Giulotto E. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res. 61 (2001) 4520-4525
173. Dutrillaux B., Aurias A., Dutrillaux A.M., Buriot D., and Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum. Genet. 62 (1982) 327-332
174. Seyschab H., Bretzel G., Friedl R., Schindler D., Sun Y., and Hoehn H. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: differences from cells arrested by X-irradiation. Mutat. Res. 308 (1994) 149-157
175. Latt S.A., Kaiser T.N., Lojewski A., Dougherty C., Juergens L., Brefach S., Sahar E., Gustashaw K., Schreck R.R., Powers M., and Lalande M. Cytogenetic and flow cytometric studies of cells from patients with Fanconi's anemia. Cytogenet. Cell Genet. 33 (1982) 133-138
176. Kupfer G.M., and D'Andrea A.D. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood 88 (1996) 1019-1025
177. Berger R., Le Coniat M., and Gendron M.C. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet. Cytogenet 69 (1993) 13-16
178. Seyschab H., Friedl R., Sun Y., Schindler D., Hoehn H., Hentze S., and Schroeder-Kurth T. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 85 (1995) 2233-2237
179. Sala-Trepat M., Rouillard D., Escarceller M., Laquerbe A., Moustacchi E., and Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res. 260 (2000) 208-215
180. Centurion S.A., Kuo H.R., and Lambert W.C. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell Res. 260 (2000) 216-221
181. Akkari Y.M., Bateman R.L., Reifsteck C.A., D'Andrea A.D., Olson S.B., and Grompe M. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab. 74 (2001) 403-412
182. Phelps R.A., Gingras H., and Hockenbery D.M. Loss of FANCC function is associated with failure to inhibit late firing replication origins after DNA cross-linking. Exp. Cell Res. 313 (2007) 2283-2292
183. Pichierri P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23 (2004) 1178-1187
184. Nakanishi K., Taniguchi T., Ranganathan V., New H.V., Moreau L.A., Stotsky M., Mathew C.G., Kastan M.B., Weaver D.T., and D'Andrea A.D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell. Biol. 4 (2002) 913-920
185. Pichierri P., and Rosselli F. Fanconi anemia proteins and the S phase checkpoint. Cell Cycle 3 (2004) 698-700
186. Demuth I., Digweed M., and Concannon P. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation. Oncogene 23 (2004) 8611-8618
187. Bae J.B., Mukhopadhyay S.S., Liu L., Zhang N., Tan J., Akhter S., Liu X., Shen X., Li L., and Legerski R.J. Snm1B/Apollo mediates replication fork collapse and S Phase checkpoint activation in response to DNA interstrand cross-links. Oncogene 27 (2008) 5045-5056
188. Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., and D'Andrea A.D. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27 (2007) 3098-3108
189. Collis S.J., Ciccia A., Deans A.J., Horejsi Z., Martin J.S., Maslen S.L., Skehel J.M., Elledge S.J., West S.C., and Boulton S.J. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol. Cell 32 (2008) 313-324
190. Collis S.J., Barber L.J., Clark A.J., Martin J.S., Ward J.D., and Boulton S.J. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol. 9 (2007) 391-401
191. Mi J., and Kupfer G.M. The Fanconi anemia core complex associates with chromatin during S phase. Blood 105 (2005) 759-766
192. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., and D'Andrea A.D. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
193. Ho G.P., Margossian S., Taniguchi T., and D'Andrea A.D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26 (2006) 7005-7015
194. Nahas S.A., Lai C.H., and Gatti R.A. Post-irradiation phosphorylation of structural maintenance chromosome 1 (SMC1) is independent of the Fanconi protein pathway. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1167-1172
195. Freie B.W., Ciccone S.L., Li X., Plett P.A., Orschell C.M., Srour E.F., Hanenberg H., Schindler D., Lee S.H., and Clapp D.W. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint. J. Biol. Chem. 279 (2004) 50986-50993
196. Marek L.R., and Bale A.E. Drosophila homologs of FANCD2 and FANCL function in DNA repair. DNA Repair (Amst) 5 (2006) 1317-1326
197. Collis S.J., Barber L.J., Ward J.D., Martin J.S., and Boulton S.J. C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair. DNA Repair (Amst) 5 (2006) 1398-1406
198. Houghtaling S., Timmers C., Noll M., Finegold M.J., Jones S.N., Meyn M.S., and Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17 (2003) 2021-2035
199. Digweed M., Demuth I., Rothe S., Scholz R., Jordan A., Grotzinger C., Schindler D., Grompe M., and Sperling K. SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11. Oncogene 21 (2002) 4873-4878
200. Lehmann A.R., Arlett C.F., Burke J.F., Green M.H., James M.R., and Lowe J.E. A derivative of an ataxia-telangiectasia (A-T) cell line with normal radiosensitivity but A-T-like inhibition of DNA synthesis. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 49 (1986) 639-643
201. Kupfer G.M., Yamashita T., Naf D., Suliman A., Asano S., and D'Andrea A.D. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 90 (1997) 1047-1054
202. Heinrich M.C., Hoatlin M.E., Zigler A.J., Silvey K.V., Bakke A.C., Keeble W.W., Zhi Y., Reifsteck C.A., Grompe M., Brown M.G., Magenis R.E., Olson S.B., and Bagby G.C. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood 91 (1998) 275-287
203. Xu B., Kim S.T., and Kastan M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21 (2001) 3445-3450
204. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., and Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30 (2002) 285-289
205. Yu X., Chini C.C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
206. Haaf T., Golub E.I., Reddy G., Radding C.M., and Ward D.C. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc. Natl. Acad. Sci. USA 92 (1995) 2298-2302
207. Maser R.S., Monsen K.J., Nelms B.E., and Petrini J.H.J. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol. 17 (1997) 6097-6104
208. Yuan S.S., Lee S.Y., Chen G., Song M., Tomlinson G.E., and Lee E.Y. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 59 (1999) 3547-3551
209. Yu V.P., Koehler M., Steinlein C., Schmid M., Hanakahi L.A., van Gool A.J., West S.C., and Venkitaraman A.R. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev. 14 (2000) 1400-1406
210. Su X., Bernal J.A., and Venkitaraman A.R. Cell-cycle coordination between DNA replication and recombination revealed by a vertebrate N-end rule degron-Rad51. Nat. Struct. Mol. Biol. 15 (2008) 1049-1058
211. Godthelp B.C., Artwert F., Joenje H., and Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21 (2002) 5002-5005
212. Godthelp B.C., Wiegant W.W., Waisfisz Q., Medhurst A.L., Arwert F., Joenje H., and Zdzienicka M.Z. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594 (2006) 39-48
213. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24 (2004) 5850-5862
214. Wilson J.B., Yamamoto K., Marriott A.S., Hussain S., Sung P., Hoatlin M.E., Mathew C.G., Takata M., Thompson L.H., Kupfer G.M., and Jones N.J. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene 27 (2008) 3641-3652
215. Saintigny Y., Delacote F., Boucher D., Averbeck D., and Lopez B.S. XRCC4 in G1 suppresses homologous recombination in S/G2, in G1 checkpoint-defective cells. Oncogene 26 (2007) 2769-2780
216. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
217. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., De Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 (2004) 1241-1248
218. Siddique M.A., Nakanishi K., Taniguchi T., Grompe M., and D'Andrea A.D. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Exp. Hematol. 29 (2001) 1448-1455
219. Tremblay C.S., Huang F.F., Habi O., Huard C.C., Godin C., Levesque G., and Carreau M. HES1 is a novel interactor of the Fanconi anemia core complex. Blood 112 (2008) 2062-2070
220. Andreassen P.R., D'Andrea A.D., and Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18 (2004) 1958-1963
221. Bogliolo M., Lyakhovich A., Callen E., Castella M., Cappelli E., Ramirez M.J., Creus A., Marcos R., Kalb R., Neveling K., Schindler D., and Surralles J. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26 (2007) 1340-1351
222. Jacquemont C., and Taniguchi T. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res. 67 (2007) 7395-7405
223. McCabe K.M., Hemphill A., Akkari Y., Jakobs P.M., Pauw D., Olson S.B., Moses R.E., and Grompe M. ERCC1 is required for FANCD2 focus formation. Mol. Genet. Metab. 95 (2008) 66-73
224. Matsushita N., Kitao H., Ishiai M., Nagashima N., Hirano S., Okawa K., Ohta T., Yu D.S., McHugh P.J., Hickson I.D., Venkitaraman A.R., Kurumizaka H., and Takata M. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19 (2005) 841-847
225. Thompson L.H. Unraveling the Fanconi anemia-DNA repair connection. Nat. Genet. 37 (2005) 921-922
226. Niedernhofer L.J. The Fanconi anemia signalosome anchor. Mol. Cell 25 (2007) 487-490
227. Niedernhofer L.J., Lalai A.S., and Hoeijmakers J.H. Fanconi anemia (cross)linked to DNA Repair. Cell 123 (2005) 1191-1198
228. Ciccia A., McDonald N., and West S.C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 77 (2008) 259-287
229. Gari K., Decaillet C., Delannoy M., Wu L., and Constantinou A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. USA 105 (2008) 16107-16112
230. Higgins N.P., Kato K., and Strauss B. A model for replication repair in mammalian cells. J. Mol. Biol. 101 (1976) 417-425
231. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., and Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23 (2003) 3417-3426
232. Ralf C., Hickson I.D., and Wu L. The Bloom's syndrome helicase can promote the regression of a model replication fork. J. Biol. Chem. 281 (2006) 22839-22846
233. Chen J. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage. Cancer Res. 60 (2000) 5037-5039
234. Wang W. A major switch for the Fanconi anemia DNA damage-response pathway. Nat. Struct. Mol. Biol. 15 (2008) 1128-1130
235. Hanada K., Budzowska M., Modesti M., Maas A., Wyman C., Essers J., and Kanaar R. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 25 (2006) 4921-4932
236. Dendouga N., Gao H., Moechars D., Janicot M., Vialard J., and McGowan C.H. Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol. Cell. Biol. 25 (2005) 7569-7679
237. McPherson J.P., Lemmers B., Chahwan R., Pamidi A., Migon E., Matysiak-Zablocki E., Moynahan M.E., Essers J., Hanada K., Poonepalli A., Sanchez-Sweatman O., Khokha R., Kanaar R., Jasin M., Hande M.P., and Hakem R. Involvement of mammalian Mus81 in genome integrity and tumor suppression. Science 304 (2004) 1822-1826
238. Abraham J., Lemmers B., Hande M.P., Moynahan M.E., Chahwan C., Ciccia A., Essers J., Hanada K., Chahwan R., Khaw A.K., McPherson P., Shehabeldin A., Laister R., Arrowsmith C., Kanaar R., West S.C., Jasin M., and Hakem R. Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J. 22 (2003) 6137-6147
239. Hoy C.A., Thompson L.H., Mooney C.L., and Salazar E.P. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res. 45 (1985) 1737-1743
240. De Silva I.U., McHugh P.J., Clingen P.H., and Hartley J.A. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucleic Acids Res. 30 (2002) 3848-3856
241. Kuraoka I., Kobertz W.R., Ariza R.R., Biggerstaff M., Essigmann J.M., and Wood R.D. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275 (2000) 26632-26636
242. Bergstralh D.T., and Sekelsky J. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?. Trends Genet. 24 (2008) 70-76
243. Niedernhofer L.J., Essers J., Weeda G., Beverloo B., de Wit J., Muijtjens M., Odijk H., Hoeijmakers J.H., and Kanaar R. The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells. EMBO J. 20 (2001) 6540-6549
244. Gupta R., Sharma S., Sommers J.A., Jin Z., Cantor S.B., and Brosh Jr. R.M. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J. Biol. Chem. 280 (2005) 25450-25460
245. Essers J., Hendriks R.W., Swagemakers S.M.A., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H.J., and Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89 (1997) 195-204
246. Peng M., Litman R., Xie J., Sharma S., Brosh Jr. R.M., and Cantor S.B. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 26 (2007) 3238-3249
247. Leung W.K., Kim J.J., Wu L., Sepulveda J.L., and Sepulveda A.R. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J. Biol. Chem. 275 (2000) 15728-15732
248. Lan L., Hayashi T., Rabeya R.M., Nakajima S., Kanno S., Takao M., Matsunaga T., Yoshino M., Ichikawa M., Riele H., Tsuchiya S., Tanaka K., and Yasui A. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells. DNA Repair 3 (2004) 135-143
249. Masuda Y., Ohmae M., Masuda K., and Kamiya K. Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins. J. Biol. Chem. 278 (2003) 12356-12360
250. Okada T., Sonoda E., Yoshimura M., Kawano Y., Saya H., Kohzaki M., and Takeda S. Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol. Cell. Biol. 25 (2005) 6103-6111
251. Sonoda E., Okada T., Zhao G.Y., Tateishi S., Araki K., Yamaizumi M., Yagi T., Verkaik N.S., van Gent D.C., Takata M., and Takeda S. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22 (2003) 3188-3197
252. Kawamoto T., Araki K., Sonoda E., Yamashita Y.M., Harada K., Kikuchi K., Masutani C., Hanaoka F., Nozaki K., Hashimoto N., and Takeda S. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol. Cell 20 (2005) 793-799
253. Andreassen P.R., Ho G.P., and D'Andrea A.D. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 27 (2006) 883-892
254. Kumaraswamy E., and Shiekhattar R. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase. Mol. Cell. Biol. 27 (2007) 6733-6741
255. Menichini P., and Linial M. SUVi and BACH1: a new subfamily of mammalian helicases?. Mutat. Res. 487 (2001) 67-71
256. Viaggi S., Gallerani E., Molina F., Nuesse M., Fronza G., Ottaggio L., Campomenosi P., Abbondandolo A., and Menichini P. Partial characterization of SUVi, a new mammalian gene induced by UV-C and expressed during the S phase of the cell cycle. Environ. Mol. Mutagen. 37 (2001) 76-84
257. Kruisselbrink E., Guryev V., Brouwer K., Pontier D.B., Cuppen E., and Tijsterman M. Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ-defective C. elegans. Curr. Biol. 18 (2008) 900-905
258. Hanada K., Budzowska M., Davies S.L., van Drunen E., Onizawa H., Beverloo H.B., Maas A., Essers J., Hickson I.D., and Kanaar R. The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks. Nat. Struct. Mol. Biol. 14 (2007) 1096-1104
259. Howlett N.G., Taniguchi T., Durkin S.G., D'Andrea A.D., and Glover T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 14 (2005) 693-701
260. Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., Martin N.M., Jackson S.P., Smith G.C., and Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434 (2005) 917-921
261. Bryant H.E., Schultz N., Thomas H.D., Parker K.M., Flower D., Lopez E., Kyle S., Meuth M., Curtin N.J., and Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434 (2005) 913-917
262. de Murcia G., de J.M., and Murcia. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem. Sci. 19 (1994) 172-176
263. El-Khamisy S.F., Masutani M., Suzuki H., and Caldecott K.W. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 31 (2003) 5526-5533
264. McCabe N., Turner N.C., Lord C.J., Kluzek K., Bialkowska A., Swift S., Giavara S., O'Connor M.J., Tutt A.N., Zdzienicka M.Z., Smith G.C., and Ashworth A. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-Ribose) polymerase inhibition. Cancer Res. 66 (2006) 8109-8115
265. Kennedy R.D., Chen C.C., Stuckert P., Archila E.M., De la Vega M.A., Moreau L.A., Shimamura A., and D'Andrea A.D. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest. 117 (2007) 1440-1449
266. Gaymes T.J., Shall S., Farzaneh F., and Mufti G.J. Chromosomal instability syndromes are sensitive to poly ADP ribose polymerase inhibitors. Haematologica 93 (2008) 1886-1889
267. Gallmeier E., Calhoun E.S., Rago C., Brody J.R., Cunningham S.C., Hucl T., Gorospe M., Kohli M., Lengauer C., and Kern S.E. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options. Gastroenterology 130 (2006) 2145-2154
268. Brown E.J., and Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14 (2000) 397-402
269. Niida H., Tsuge S., Katsuno Y., Konishi A., Takeda N., and Nakanishi M. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J. Biol. Chem. 280 (2005) 39246-39252
270. Yamaguchi-Iwai Y., Sonoda E., Sasaki M.S., Morrison C., Haraguchi T., Hiraoka Y., Yamashita Y.M., Yagi T., Takata M., Price C., Kakazu N., and Takeda S. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J. 18 (1999) 6619-6629
271. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., and Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionising radiation. Proc. Natl. Acad. Sci. USA 96 (1999) 7376-7381
272. Shen S.X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., Guan X.Y., Ried T., and Deng C.X. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17 (1998) 3115-3124
273. Haring S.J., Mason A.C., Binz S.K., and Wold M.S. Cellular functions of human RPA1. Multiple roles of domains in replication, repair, and checkpoints. J. Biol. Chem. 283 (2008) 19095-19111
274. Warren M., Lord C.J., Masabanda J., Griffin D., and Ashworth A. Phenotypic effects of heterozygosity for a BRCA2 mutation. Hum. Mol. Genet. 12 (2003) 2645-2656
275. Sonoda E., Sasaki M., Buerstedde J.M., Bezzubova O., Shinohara A., Ogazwa H., Takata M., Yamaguchi-Iwai Y., and Takeda S. Rad51 deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17 (1998) 598-608
276. Tauchi H., Kobayashi J., Morishima K., Van Gent D.C., Shiraishi T., Verkaik N.S., VanHeems D., Ito E., Nakamura A., Sonoda E., Takata M., Takeda S., Matsuura S., and Komatsu K. Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420 (2002) 93-98
277. Zhu J., Petersen S., Tessarollo L., and Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11 (2001) 105-109
278. Liu X., Lao Y., Yang I.Y., Hecht S.S., and Moriya M. Replication-coupled repair of crotonaldehyde/acetaldehyde-induced guanine-guanine interstrand cross-links and their mutagenicity. Biochemistry 45 (2006) 12898-12905
279. Wang L.C., Stone S., Hoatlin M.E., and Gautier J. Fanconi anemia proteins stabilize replication forks. DNA Repair (Amst.) 7 (2008) 1973-1981
280. Hejna J., Holtorf M., Hines J., Mathewson L., Hemphill A., Al-Dhalimy M., Olson S.B., and Moses R.E. Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway. J. Biol. Chem. 283 (2008) 9844-9851
281. Kolas N.K., and Durocher D. DNA repair: DNA polymerase zeta and Rev1 break in. Curr. Biol. 16 (2006) R296-R299
282. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
283. Oestergaard V.H., Langevin F., Kuiken H.J., Pace P., Niedzwiedz W., Simpson L.J., Ohzeki M., Takata M., Sale J.E., and Patel K.J. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell 28 (2007) 798-809